Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All exercise studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchExerciseExercise (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Mortality 76% Improvement Relative Risk Hospitalization 51% Exercise for COVID-19  Buckley et al. c19early.org Favors exercise Favors inactivity

Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19

Buckley et al., European Journal of Preventive Cardiology, doi:10.1093/eurjpc/zwaa135
Jul 2021  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Exercise for COVID-19
9th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 66 studies.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
PSM retrospective 643 COVID-19 patients with cardiovascular disease undergoing exercise rehabilitation within 3 months of diagnosis, showing significantly lower re-hospitalization and mortality with exercise rehabilitation.
risk of death, 75.8% lower, RR 0.24, p < 0.001, high activity levels 10 of 639 (1.6%), low activity levels 41 of 638 (6.4%), NNT 21, odds ratio converted to relative risk.
risk of hospitalization, 50.9% lower, RR 0.49, p < 0.001, high activity levels 97 of 643 (15.1%), low activity levels 198 of 643 (30.8%), NNT 6.4, odds ratio converted to relative risk.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Buckley et al., 5 Jul 2021, retrospective, USA, peer-reviewed, 7 authors.
This PaperExerciseAll
Abstract: RESEARCH LETTER European Journal of Preventive Cardiology doi:10.1093/eurjpc/zwaa135 Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19 Benjamin J.R. Buckley 1*, Stephanie L. Harrison1, Elnara Fazio-Eynullayeva2, Paula Underhill3, Ian D. Jones4, Nefyn Williams5, and Gregory Y.H. Lip1,4,6 1 Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, William Henry Duncan Building, Liverpool L7 8TX, UK; 2TriNetX Inc, Cambridge, MA, USA; 3TriNetX Inc, London, UK; 4Liverpool Centre for Cardiovascular Science, Liverpool John Moores University, Liverpool, UK; 5Department of Primary Care and Mental Health, University of Liverpool, UK; and 6Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark Received 21 October 2020; revised 9 November 2020; editorial decision 10 November 2020 The COVID-19 pandemic has caused global health, social, and economic system challenges. In an effort to try and reduce transmission rates, most countries have varying levels of societal ‘lockdowns’ and social restrictions in place. This creates a unique challenge for the promotion of physical activity and exercise, which we know has profound physical and mental health benefits. Although there was initial promise of increased population interest in physical activity and exercise at the beginning of the COVID-19 pandemic,1 recent large-scale data from over 455 000 people has demonstrated a 27% decrease in average daily steps within 30 days of the pandemic declaration.2 It may therefore be more important now than ever to facilitate physical activity and exercise promotion during and post-COVID19. Despite, recent collaborative efforts developing post-COVID-19 guidelines for athletes returning to exercise,3 limited evidence is available for the impact of exercise and cardiac rehabilitation (CR) on clinical outcomes following-COVID-19. Secondary prevention through comprehensive CR has been recognized as the most costeffective intervention to ensure favourable outcomes across a wide spectrum of cardiovascular diseases.4 Given there is a high prevalence of cardiovascular disease among patients with COVID-19, and >7% experience COVID-19 induced myocardial injury,5 CR following COVID-19 infection warrants investigation. The objective of this study was therefore to compare mortality, hospitalization, and cardiovascular comorbidity between patients with cardiovascular disease and COVID-19 with and without an electronic medical record (EMR) of CR or exercise programmes. This retrospective observational study was conducted in October 2020 with anonymized data provided by TriNetX, a global federated health research network with access to EMRs from participating academic medical centres, specialty physician practices, and community hospitals, predominantly in the USA. Patients with COVID-19 were identified via Centers for Disease Control and Prevention (CDC) coding using ICD-10-CM codes, or specific laboratory Logical .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. Observation Identifiers Names and Codes.6 All patients were aged >_18 years with COVID-19 recorded in EMRs between 20 January 2020 (date COVID-19 first confirmed in the USA)7 and 26 May 2020 (to allow 4-month follow-up). Cardiac rehabilitation was..
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit